Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Burger

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
Oncoimmunology|October 17, 2022
AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastomaM I Strecker, K Wlotzka, F Strassheimer, et al.
British Journal of Cancer|March 19, 2025
CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastomaF Strassheimer, P Elleringmann, G Ludmirski, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
Oncoimmunology|October 17, 2022
AAV-mediated gene transfer of a checkpoint inhibitor in combination with HER2-targeted CAR-NK cells as experimental therapy for glioblastomaM I Strecker, K Wlotzka, F Strassheimer, et al.
British Journal of Cancer|March 19, 2025
CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastomaF Strassheimer, P Elleringmann, G Ludmirski, et al.
Pageof 4